• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节病中肺动脉高压的临床预测因素。

Clinical predictors of pulmonary hypertension in sarcoidosis.

作者信息

Bourbonnais J M, Samavati L

机构信息

Dept of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Wayne State University School of Medicine-Detroit Medical Center, Detroit, MI 48201, USA.

出版信息

Eur Respir J. 2008 Aug;32(2):296-302. doi: 10.1183/09031936.00175907. Epub 2008 Apr 2.

DOI:10.1183/09031936.00175907
PMID:18385166
Abstract

Pulmonary hypertension (PH) adversely affects outcome in sarcoidosis and is an important predictor of mortality in these patients. Early and accurate diagnosis of this complication may improve outcome. The current authors hypothesised that integration of 6-min walk test (6MWT) as part of the evaluation leads to an earlier diagnosis of this complication. A total of 162 patients with sarcoidosis underwent 6MWT. Demographic and pulmonary function results were analysed. Patients were further assessed by echocardiography and right heart catheterisation when clinically indicated. Patients with sarcoidosis-associated PH had significantly decreased results on pulmonary function testing. They also walked shorter distances and desaturated to lower levels on 6MWT. On logistic regression analyses, significant predictors of PH were oxygen saturation <90% on 6MWT (odds ratio (OR) 12.1, 95% confidence interval (CI) 3.66-19.73) and diffusing capacity of the lung for carbon monoxide <60% predicted (OR 7.3, 95% CI 1.98-24.82). Moreover, by combining the results of oxygen saturation at 6 min with those of echocardiography, the ability to correctly predict the presence of PH by right heart catheterisation was improved. Patients with diffusing capacity of the lung for carbon monoxide <60% predicted and oxygen desaturation <90% on 6-min walk test have a high likelihood of pulmonary hypertension and should undergo further evaluation for the presence of this disorder.

摘要

肺动脉高压(PH)对结节病的预后产生不利影响,是这些患者死亡率的重要预测指标。早期准确诊断这一并发症可能改善预后。本文作者推测,将6分钟步行试验(6MWT)纳入评估可更早诊断这一并发症。共有162例结节病患者接受了6MWT。分析了人口统计学和肺功能结果。临床指征明确时,进一步通过超声心动图和右心导管检查对患者进行评估。结节病相关PH患者的肺功能测试结果显著降低。他们在6MWT中的步行距离也较短,血氧饱和度下降到更低水平。在逻辑回归分析中,PH的显著预测指标为6MWT时血氧饱和度<90%(比值比(OR)12.1,95%置信区间(CI)3.66 - 19.73)和预测的一氧化碳弥散量<60%(OR 7.3,95%CI 1.98 - 24.82)。此外,将6分钟时的血氧饱和度结果与超声心动图结果相结合,可提高通过右心导管检查正确预测PH存在的能力。预测的一氧化碳弥散量<60%且6分钟步行试验时血氧饱和度下降<90%的患者发生肺动脉高压的可能性很高,应进一步评估是否存在这种疾病。

相似文献

1
Clinical predictors of pulmonary hypertension in sarcoidosis.结节病中肺动脉高压的临床预测因素。
Eur Respir J. 2008 Aug;32(2):296-302. doi: 10.1183/09031936.00175907. Epub 2008 Apr 2.
2
Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.淋巴管平滑肌瘤病中的肺动脉高压:患病率、严重程度及一氧化碳弥散能力作为一种筛查方法的作用
Orphanet J Rare Dis. 2017 Apr 20;12(1):74. doi: 10.1186/s13023-017-0626-0.
3
Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.肺功能接近正常的结节病相关性肺动脉高压患者。
Int J Tuberc Lung Dis. 2013 Mar;17(3):406-11. doi: 10.5588/ijtld.12.0428.
4
Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.系统性硬化症伴间质性肺疾病患者运动诱导性低氧血症的预测因素。
Respir Care. 2014 Jan;59(1):75-80. doi: 10.4187/respcare.02452. Epub 2013 Jun 13.
5
Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension.结节病相关肺动脉高压患者独特的临床、影像学和功能特征。
Chest. 2005 Sep;128(3):1483-9. doi: 10.1378/chest.128.3.1483.
6
Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study).弥漫性实质性肺疾病生存的新星:FVC 和运动性低氧饱和度(单中心研究)。
Turk J Med Sci. 2018 Aug 16;48(4):826-832. doi: 10.3906/sag-1802-196.
7
A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis.慢性过敏性肺炎肺动脉高压的血液动力学研究。
Eur Respir J. 2014 Aug;44(2):415-24. doi: 10.1183/09031936.00010414. Epub 2014 Apr 17.
8
Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.超声心动图、6 分钟步行距离和距离饱和度乘积预测特发性肺纤维化中的肺动脉高压。
Respir Care. 2010 May;55(5):584-8.
9
Pulmonary hypertension in chronic lung diseases.慢性肺部疾病相关肺动脉高压。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036.
10
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.特发性肺纤维化:生理学变化及六分钟步行试验的预后价值
Am J Respir Crit Care Med. 2006 Oct 1;174(7):803-9. doi: 10.1164/rccm.200604-488OC. Epub 2006 Jul 6.

引用本文的文献

1
Reddish-Brown Dermal Papules and Plaques in a Patient With Kidney Stones.肾结石患者身上的红棕色皮肤丘疹和斑块
Cureus. 2025 May 30;17(5):e85076. doi: 10.7759/cureus.85076. eCollection 2025 May.
2
Fibrotic Pulmonary Sarcoidosis-From Pathogenesis to Management.纤维化型肺结节病——从发病机制到治疗
J Clin Med. 2025 Mar 30;14(7):2381. doi: 10.3390/jcm14072381.
3
Sarcoidosis-Associated Pulmonary Hypertension.结节病相关的肺动脉高压
Medicina (Kaunas). 2025 Feb 14;61(2):342. doi: 10.3390/medicina61020342.
4
Sarcoidosis-Associated Pulmonary Hypertension.结节病相关性肺动脉高压
J Clin Med. 2024 Apr 2;13(7):2054. doi: 10.3390/jcm13072054.
5
Imaging of Pulmonary Sarcoidosis-A Review.肺结节病的影像学——综述
J Clin Med. 2024 Jan 31;13(3):822. doi: 10.3390/jcm13030822.
6
Sarcoidosis Associated Pulmonary Hypertension.结节病相关性肺动脉高压
Biomedicines. 2024 Jan 13;12(1):177. doi: 10.3390/biomedicines12010177.
7
Pulmonary Function in Pulmonary Sarcoidosis.肺结节病的肺功能
J Clin Med. 2023 Oct 24;12(21):6701. doi: 10.3390/jcm12216701.
8
Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective.评估利奥西呱治疗肺动脉高压的真实世界研究。
Vasc Health Risk Manag. 2022 Oct 20;18:823-832. doi: 10.2147/VHRM.S383572. eCollection 2022.
9
Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension.结节病相关肺动脉高压中的肺动脉高压相关基因变异
Diagnostics (Basel). 2022 Oct 21;12(10):2564. doi: 10.3390/diagnostics12102564.
10
Modulatory role of macrophage migration inhibitory factor on cytokines and clinical features of sarcoidosis.巨噬细胞移动抑制因子对结节病细胞因子和临床特征的调节作用。
Sci Rep. 2022 Oct 7;12(1):16906. doi: 10.1038/s41598-022-21212-5.